Unstimulated Saliva-Related Caries Risk Factors in Individuals with Cystic Fibrosis: A Cross-Sectional Analysis of Unstimulated Salivary Flow, PH, and Buffering Capacity
Overview
Affiliations
Salivary flow rate, pH, and buffering capacity are associated with dental caries, but studies from the cystic fibrosis (CF) literature are inconclusive regarding these salivary factors and caries. The aim of this study was to evaluate these factors and their associations with dental caries in individuals with CF. Unstimulated whole saliva was collected from individuals aged 6-20 years at Seattle Children's Hospital CF Clinic, USA (n = 83). Salivary flow rate was measured in milliliters per minute. Salivary pH was assessed using a laboratory pH meter. Buffering capacity was assessed by titration with HCl. The outcome measure was caries prevalence, defined as the number of decayed, missing, or filled primary and permanent tooth surfaces. Spearman's rank correlation coefficient and the t test were used to test for bivariate associations. Multiple variable linear regression models were used to (1) run confounder-adjusted analyses and (2) assess for potential interactions. There was no significant association between salivary flow rate or buffering capacity and caries prevalence. There was a significant negative association between salivary pH and caries prevalence, but this association was no longer significant after adjusting for age. There was no significant interaction between salivary flow rate and buffering capacity or between antibiotic use and the 3 salivary factors. Our results indicate that unstimulated salivary factors are not associated with dental caries prevalence in individuals with CF. Future studies should investigate other potential saliva-related caries risk factors in individuals with CF such as cariogenic bacteria levels, salivary host defense peptide levels, and medication use.
Oral health and related outcomes in children and adolescents with cystic fibrosis: a scoping review.
Chin D, Ramalingam L, Harrison J, Silva M Eur Arch Paediatr Dent. 2024; 25(4):455-469.
PMID: 38990412 PMC: 11341622. DOI: 10.1007/s40368-024-00885-8.
Oral health in individuals with cystic fibrosis: A cross-sectional study.
Abreu de Moraes D, Lia E, Jacome L, de Azevedo Pedrosa Cunha C, de Freitas Velloso Monte L Heliyon. 2024; 10(3):e25241.
PMID: 38356573 PMC: 10865253. DOI: 10.1016/j.heliyon.2024.e25241.
Alenazi H, Baseer M, Mohammed AlMugeiren O, Ingle N Int J Gen Med. 2024; 16:6115-6125.
PMID: 38162688 PMC: 10756067. DOI: 10.2147/IJGM.S437563.
Ramadoss R, Krishnan R, Raman S, Padmanaban R, Anbuelangovan N, Eswaramoorthy R BMC Oral Health. 2023; 23(1):334.
PMID: 37246232 PMC: 10226253. DOI: 10.1186/s12903-023-03049-0.
Oral care considerations for people with cystic fibrosis: a cross-sectional qualitative study.
Coffey N, O Leary F, Burke F, Plant B, Roberts A, Hayes M BDJ Open. 2023; 9(1):11.
PMID: 36906647 PMC: 10008013. DOI: 10.1038/s41405-023-00136-w.